Cardlytics, Inc. (NASDAQ:CDLX) COO Sells $278,884.56 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) COO Amit Gupta sold 23,416 shares of the firm’s stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $11.91, for a total transaction of $278,884.56. Following the completion of the transaction, the chief operating officer now directly owns 122,676 shares of the company’s stock, valued at $1,461,071.16. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Cardlytics Price Performance

CDLX stock opened at $12.31 on Friday. The firm has a 50 day simple moving average of $11.29 and a two-hundred day simple moving average of $9.66. The stock has a market cap of $592.97 million, a PE ratio of -3.56 and a beta of 1.44. Cardlytics, Inc. has a one year low of $4.94 and a one year high of $20.52. The company has a debt-to-equity ratio of 1.91, a current ratio of 1.31 and a quick ratio of 1.31.

Cardlytics (NASDAQ:CDLX) last announced its earnings results on Thursday, March 14th. The company reported ($0.14) earnings per share (EPS) for the quarter. The company had revenue of $89.17 million during the quarter. Cardlytics had a negative return on equity of 25.38% and a negative net margin of 43.56%.

Institutional Investors Weigh In On Cardlytics

Institutional investors and hedge funds have recently bought and sold shares of the business. Invesco Ltd. increased its stake in shares of Cardlytics by 538.1% during the third quarter. Invesco Ltd. now owns 803,241 shares of the company’s stock valued at $13,253,000 after buying an additional 677,354 shares during the period. Raymond James Financial Services Advisors Inc. purchased a new stake in Cardlytics in the third quarter worth $5,258,000. Vanguard Group Inc. boosted its holdings in Cardlytics by 13.0% in the third quarter. Vanguard Group Inc. now owns 2,011,705 shares of the company’s stock valued at $33,193,000 after acquiring an additional 231,303 shares in the last quarter. EAM Investors LLC purchased a new position in Cardlytics during the 3rd quarter valued at $2,758,000. Finally, General Equity Holdings LP raised its holdings in Cardlytics by 31.0% in the 4th quarter. General Equity Holdings LP now owns 624,058 shares of the company’s stock worth $5,748,000 after purchasing an additional 147,843 shares in the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Craig Hallum raised Cardlytics from a “hold” rating to a “buy” rating and raised their price target for the stock from $10.00 to $18.00 in a report on Friday, March 15th. Lake Street Capital raised their price objective on shares of Cardlytics from $13.00 to $18.00 and gave the company a “buy” rating in a research report on Friday, March 15th. Finally, Needham & Company LLC lifted their price objective on Cardlytics from $15.00 to $17.00 and gave the company a “buy” rating in a research note on Tuesday, April 9th.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.